determin
preval
antibodi
felin
coronaviru
fcov
serotyp
switzerland
associ
differ
diseas
manifest
serolog
studi
base
immunofluoresc
test
conduct
swiss
field
cat
use
transmiss
gastroenter
viru
tgev
fcov
type
fcov
type
antigen
total
serum
sampl
collect
context
differ
studi
natur
infect
cat
test
current
studi
reveal
appar
preval
fcov
serotyp
preval
serotyp
switzerland
fcov
type
virus
induc
higher
antibodi
titer
fcov
type
frequent
associ
clinic
sign
andor
felin
infecti
periton
antibodi
develop
seven
cat
experiment
infect
fcov
type
reveal
progress
durat
infect
antibodi
fcov
type
significantli
increas
fcov
type
signific
relationship
antibodi
titer
tgev
fcov
fcov
tgev
antigen
detect
highest
proport
seroposit
cat
conclud
vaccin
fcov
base
fcov
type
antigen
serodiagnosi
fcov
infect
tgev
use
attain
highest
diagnost
effici
serolog
use
addit
clinic
sign
hematolog
clinic
chemistri
result
aid
diagnos
clinic
fip
tgev
show
diagnost
effici
equal
fcov
antigen
four
serum
sampl
cat
collect
week
experiment
infect
fcovrm
intens
research
done
sinc
first
descript
diseas
pattern
felin
infecti
periton
fip
yet
epidemiolog
pathogenesi
fatal
diseas
fip
caus
coronaviru
still
fulli
understood
shown
fip
singl
import
infecti
caus
death
young
cat
result
loss
seroposit
kitten
first
year
life
pathogenesi
gener
accept
today
felin
coronaviru
fcov
fipinduc
virus
fipv
repres
virul
variant
viru
rather
separ
viru
speci
fcov
mutant
caus
clinic
sign
although
present
high
viral
load
sporad
mutant
pathogen
induc
fip
case
fcov
infect
found
induc
mild
enter
symptom
postul
earlier
harmless
fcov
restrict
intestin
tract
fip
develop
would
result
capabl
viru
mutant
induc
system
infect
meantim
demonstr
revers
transcript
rt
pcr
fcov
gener
induc
system
infect
moreov
fcov
fipv
remain
serolog
genet
indistinguish
antigenet
coronavirus
divid
five
group
togeth
canin
coronaviru
ccov
transmiss
gastroenter
viru
tgev
fcov
belong
group
cat
seem
suscept
group
coronavirus
felin
strain
thought
origin
recombin
fcov
group
virus
ccov
base
vitro
neutral
test
fcov
classifi
two
serotyp
differ
growth
characterist
cell
cultur
antigenet
relationship
tgev
ccov
howev
serotyp
caus
fip
serolog
distinct
fcov
type
type
like
associ
differ
gene
sequenc
monoclon
antibodi
protein
readili
differenti
fcov
subtyp
furthermor
fcov
type
differ
cell
tropism
explain
chang
protein
bind
differ
receptor
demonstr
previous
cat
recov
fcov
infect
develop
especi
high
titer
protein
mani
new
strain
recent
isol
phylogenet
examin
suggest
spectrum
strain
rang
felinelik
caninelik
rather
two
distinct
serotyp
whichev
system
appli
classifi
fcov
associ
certain
fcov
strain
abil
induc
diseas
could
yet
elucid
knowledg
serotyp
circul
given
popul
import
prerequisit
develop
fcov
vaccin
vaccin
close
relat
field
virus
present
studi
initi
determin
seropreval
fcov
type
switzerland
find
potenti
associ
serotyp
certain
diseas
manifest
addit
aim
character
immun
respons
experiment
infect
fcov
total
serum
sampl
collect
natur
experiment
infect
cat
differ
studi
test
fcov
antibodi
tabl
kinet
antibodi
develop
determin
sampl
collect
cat
oral
infect
fcovrm
serotyp
strain
blood
taken
weekli
first
two
month
monthli
thereaft
week
infect
tabl
group
e
evalu
preval
fcov
serotyp
antibodi
field
sera
collect
use
collect
randomli
select
sampl
cat
consid
healthi
owner
veterinarian
investig
possibl
relationship
presenc
antibodi
two
serotyp
clinic
sign
sampl
mention
healthi
cat
clinic
ill
cat
test
latter
present
veterinarian
one
clinic
sign
diseas
includ
fever
cachexia
depress
diarrhea
gastrointestin
tract
andor
abdomin
problem
cat
origin
part
switzerland
differ
age
breed
husbandri
manag
sex
tabl
group
character
relationship
presenc
antibodi
one
fcov
serotyp
fip
serum
sampl
evalu
randomli
chosen
collect
histopatholog
confirm
fip
case
accumul
tabl
group
c
refer
group
randomli
select
sera
collect
diseas
cat
without
fip
serum
sampl
store
clinic
laboratori
vetsuiss
faculti
univers
zurich
time
period
tabl
group
determin
immunolog
relationship
fcov
tgev
serum
sampl
group
test
respect
antibodi
immunofluorensc
assay
ifa
fcov
slide
materi
dilut
rins
buffer
control
sera
mount
fluid
kindli
donat
vmrd
inc
pullman
wa
two
differ
type
slide
use
fcov
type
type
grown
crandel
felin
kidney
cell
crfk
posit
control
sera
obtain
ascit
confirm
fip
case
titrat
fcov
fcov
slide
neg
control
sera
collect
clinic
healthi
cat
serial
dilut
prepar
sampl
first
screen
done
dilut
avoid
fals
posit
result
crosscontamin
slide
endpoint
titer
determin
test
posit
sampl
higher
dilut
wherea
neg
sampl
test
lower
dilut
stain
procedur
indirect
ifa
perform
accord
manufactur
protocol
briefli
dilut
sera
incub
min
slide
wash
min
conjug
sheep
antifelin
immunoglobulin
g
igg
polyclon
antiserum
conjug
fluorescein
isothiocyan
ad
min
wash
step
surfac
slide
dri
absorb
paper
prevent
well
dri
well
contain
infect
cell
uninfect
cell
serv
intern
neg
control
serum
sampl
antibodi
type
higher
type
design
antibodi
type
vice
versa
antibodi
tgev
test
accord
method
osterhau
horzinek
qualiti
control
fcov
tgev
slide
test
slide
absenc
potenti
viral
contamin
origin
variou
felin
pathogen
handl
laboratori
cell
remov
slide
use
steril
scalpel
blade
suspend
l
phosphatebuff
salin
pb
total
nucleic
acid
tna
extract
use
magna
pure
lc
total
nucleic
acid
isol
kit
roch
diagnost
rotkreuz
switzerland
elut
l
elut
buffer
extract
test
realtim
rtpcr
pcr
follow
pathogen
fcov
felin
leukemia
viru
felv
proviru
pcr
felin
immunodefici
viru
fiv
felin
herp
viru
felin
parvoviru
fpv
felin
caliciviru
fcv
fcv
test
follow
modif
forward
primer
gga
tga
act
acc
cgc
caa
revers
primer
atg
cgg
ctc
tga
tgg
ctt
gaa
act
probe
fam
tcg
gtg
ttt
gat
ttg
gcc
tamra
c
help
person
commun
uninfect
cell
present
slide
serv
intern
neg
control
show
unspecif
fluoresc
slide
test
mycoplasma
contamin
pcr
molecular
character
fcov
isol
character
fcov
strain
use
ifa
infect
cell
lyse
directli
slide
use
l
lysi
buffer
rlt
buffer
rneasi
mini
kit
qiagen
hombrechtikon
switzerland
viral
rna
extract
mean
rneasi
mini
kit
qiagen
extract
rna
check
fcov
realtim
rtpcr
region
base
pair
gene
fcov
amplifi
use
follow
primer
set
primer
set
forward
primer
ctt
aat
gct
tat
gtg
tct
caa
revers
primer
gcc
att
caa
ggt
caa
primer
set
forward
primer
cac
tta
atg
ctt
atg
tgt
ctc
revers
primer
tcc
tgt
tga
gcc
att
caa
primer
set
forward
primer
act
taa
tgc
att
tgt
gtc
revers
primer
caa
ttc
tat
tga
gcc
att
caa
primer
set
forward
primer
ctt
aat
gct
tat
gtg
tct
revers
primer
aca
tac
caa
ggc
primer
set
forward
primer
act
taa
tgc
tta
tgt
revers
primer
sequenc
briefli
l
rna
amplifi
use
superscript
iii
onestep
rtpcr
system
platinum
taq
kit
invitrogen
life
technolog
basel
switzerland
concentr
primer
total
volum
l
pcr
cycl
condit
follow
min
rt
step
min
cycl
denatur
anneal
min
elong
follow
min
pcr
product
convent
pcr
analyz
agaros
gel
amplicon
purifi
use
minelut
gel
extract
kit
qiagen
sequenc
side
cycl
sequenc
perform
approxim
ng
dna
pmol
productspecif
primer
use
bigdy
termin
cycl
sequenc
readi
reaction
kit
appli
biosystem
rotkreuz
switzerland
cycl
condit
follow
min
cycl
follow
min
product
purifi
use
dyeex
spin
column
qiagen
analyz
abi
prism
genet
analyz
appli
biosystem
sequenc
obtain
five
primer
set
align
one
consensu
sequenc
seqscap
version
appli
biosystem
compar
refer
sequenc
fcov
gene
deposit
genbank
typic
type
strain
type
strain
statist
evalu
statist
analys
perform
use
statview
sa
institut
inc
cari
nc
microsoft
excel
character
frequenc
antibodi
serotyp
respect
signific
differ
differ
group
cat
appli
evalu
height
titer
differ
group
cat
titer
divid
two
group
tabl
associ
natur
symptom
serotyp
evalu
mean
multivari
logist
regress
model
determin
immunolog
relationship
fcov
tgev
coeffici
correl
regress
coeffici
use
least
squar
method
appli
character
kinet
antibodi
develop
signific
differ
antibodi
titer
analyz
analysi
varianc
anova
factori
repeat
measur
method
fisher
protect
leastsignific
differ
post
hoc
test
factori
anova
comparison
mean
titer
kruskalw
mannwhitney
u
test
use
comparison
group
perform
use
test
post
hoc
cell
contribut
well
multivari
logist
regress
model
p
valu
consid
statist
signific
present
frequenc
distribut
fig
box
plot
use
upper
lower
level
box
repres
quartil
line
repres
median
whisker
quartil
outlier
shown
individu
dot
qualiti
control
fcov
tgev
slide
rtpcr
pcr
test
potenti
contamin
pathogen
yield
neg
result
except
fcov
rtpcr
highli
posit
taqman
cycl
threshold
valu
fcov
type
fcov
type
respect
suggest
presenc
compar
amount
viral
rna
molecular
character
fcov
isol
partial
sequenc
gene
fcov
isol
slide
genbank
access
number
respect
reveal
high
homolog
prototyp
fcov
type
strain
respect
tabl
develop
antibodi
titer
fcov
type
experiment
infect
cours
infect
follow
seven
cat
experiment
infect
fcov
type
strain
period
week
fig
antibodi
titer
type
type
increas
significantli
week
experi
note
cat
surviv
experi
show
clinic
sign
rise
fcov
antibodi
titer
reflect
fip
develop
preval
fcov
serotyp
switzerland
among
clinic
healthi
cat
group
fcov
seroposit
test
anim
titer
fcov
higher
fcov
cat
vice
versa
show
ident
titer
fcov
type
fig
statist
signific
associ
husbandri
condit
multicat
vs
singl
cat
household
preval
fcov
serotyp
test
p
high
titer
fcov
frequent
found
cat
multicat
singl
cat
household
although
differ
signific
test
p
antibodi
fcov
type
tendenc
less
frequent
multicat
household
test
p
swiss
catteri
group
b
antibodi
type
predomin
catteri
antibodi
type
equal
height
antibodi
type
predomin
none
catteri
fig
cat
analyz
antibodi
titer
fcov
type
significantli
higher
fcov
type
fig
associ
fcov
serotyp
clinic
manifest
among
field
sera
group
seroposit
fcov
type
type
significantli
higher
cat
clinic
sign
healthi
cat
test
p
associ
antibodi
type
predomin
import
clinic
sign
howev
statist
signific
associ
found
presenc
antibodi
type
six
categori
clinic
sign
previous
found
associ
possibl
fcov
infect
multivari
logist
regress
model
p
sampl
histopatholog
confirm
fip
case
group
c
seroposit
cat
type
titer
higher
type
remain
anim
ident
titer
serotyp
none
cat
titer
type
higher
type
fig
refer
group
nonfip
case
group
seroneg
test
higher
type
type
show
ident
titer
type
cat
titer
type
higher
type
fig
distribut
titer
fcov
serotyp
differ
significantli
group
test
p
compar
nonfip
case
fip
case
significantli
higher
seropreval
fcov
antibodi
group
test
p
addit
preval
cat
antibodi
fcov
type
titer
significantli
higher
cat
antibodi
fcov
type
equal
titer
kruskalw
p
fig
box
plot
distribut
fcov
serotyp
tgev
antibodi
titer
fip
group
c
nonfip
case
group
fip
case
show
significantli
higher
fcovtgev
antibodi
titer
nonfip
case
mannwhitney
u
test
p
fcov
tgev
ratio
median
titer
fip
nonfip
case
ident
fcov
tgev
antigen
antibodi
fcov
significantli
higher
fip
group
refer
group
test
p
associ
could
detect
height
titer
type
clinic
sign
test
p
howev
mean
titer
fcov
type
confirm
fip
case
statist
higher
titer
fcov
type
control
group
without
fip
test
p
fig
immunolog
relationship
fcov
type
tegv
diagnost
effici
posit
correl
titer
fcov
r
p
fcov
type
tgev
r
p
fcov
type
tgev
r
p
confirm
close
immunolog
relationship
three
antigen
test
number
posit
ifa
result
fcov
similar
obtain
fcov
lower
use
tgev
fig
sampl
test
posit
tgev
neg
fcov
sampl
titer
titer
titer
serolog
addit
evalu
clinic
paramet
hematolog
clinic
chemistri
result
use
aid
diagnos
clinic
fip
tgev
antigen
yield
diagnost
effici
ident
fcov
serotyp
fig
analyz
serum
sampl
swiss
field
cat
experiment
infect
cat
fcov
antibodi
use
fcov
type
type
tgev
slide
found
preval
fcov
antibodi
greater
fcov
antibodi
cat
equal
high
titer
type
use
molecular
assay
demonstr
antigen
prepar
free
contamin
agent
includ
felv
fiv
fpv
fcv
base
sequenc
analys
part
fcov
gene
clear
assign
two
virus
prototyp
fcov
possibl
confirm
valid
slide
serodiagnosi
antibodi
fcov
differenti
antibodi
type
type
occur
late
experiment
fcov
infect
antibodi
develop
fcov
follow
experiment
cat
becam
clear
observ
period
week
antibodi
fcov
show
signific
increas
fcov
suggest
earli
phase
infect
crossreact
epitop
type
respons
compar
titer
experi
conclud
b
lymphocyt
involv
undergo
constant
stimul
result
increas
concentr
antibodi
affin
matur
lead
ever
higher
antibodi
specif
infect
agent
ie
fcov
fcov
henc
serolog
differenti
antibodi
fcov
may
possibl
earli
phase
infect
infect
result
increas
antibodi
concentr
specif
preval
increas
fcov
serotyp
switzerland
preval
antibodi
fcov
healthi
field
cat
found
vari
japan
austria
report
fcov
seropreval
healthi
swiss
cat
twofold
higher
found
studi
explan
increas
includ
differ
sampl
select
andor
serolog
test
earlier
studi
tgev
slide
use
compar
tgev
fcov
type
slide
three
antigen
gave
compar
result
therefor
preval
increas
attribut
antigen
use
studi
criteria
sampl
submiss
ident
ie
veterinarian
submit
sampl
person
interest
obtain
result
two
studi
similar
respect
origin
sampl
singl
versu
multicat
household
thu
observ
increas
may
inde
reflect
increas
seropreval
found
predominantli
fcov
type
antibodi
agreement
serolog
survey
although
distribut
vari
degre
parallel
experiment
studi
hypothes
serum
sampl
antibodi
titer
fcov
type
greater
type
origin
cat
fcov
type
infect
week
field
cat
titer
fcov
type
equal
type
may
repres
cat
infect
serotyp
either
viru
short
period
cat
titer
fcov
type
greater
type
consid
infect
type
viru
assum
antibodi
develop
infect
type
fcov
mirror
type
infect
specif
antibodi
fcov
type
increas
type
time
overal
becom
clear
true
preval
type
infect
determin
precis
statu
cat
display
ident
titer
type
remain
unresolv
earlier
report
state
cat
infect
fcov
readili
superinfect
antigen
relat
coronavirus
howev
observ
could
confirm
pcr
studi
conduct
other
among
cat
ident
titer
serotyp
major
high
titer
may
reflect
coinfect
serotyp
altern
could
explain
infect
caus
strain
ident
immunolog
equal
relat
strain
use
current
studi
addit
equal
titer
fcov
type
could
also
ex
plain
antibodi
structur
protein
present
virus
n
protein
base
assumpt
viru
serotyp
within
catteri
cluster
around
one
strain
test
pool
serum
sampl
randomli
select
swiss
catteri
predomin
serotyp
none
catteri
antibodi
titer
type
predomin
along
low
seropreval
type
individu
cat
data
support
hypothesi
type
typic
known
type
occur
frequent
field
spite
type
virus
frequent
use
laboratori
may
reflect
import
field
rather
eas
cultiv
vitro
report
type
fcov
origin
recombin
coronavirus
cat
dog
associ
presenc
dog
serotyp
fcov
could
confirm
due
retrospect
natur
studi
inform
presenc
dog
record
could
imagin
type
virus
suboptim
replic
activ
vivo
may
explain
lower
viral
load
result
infect
virus
may
explain
significantli
lower
antibodi
titer
cat
infect
fcov
type
compar
infect
type
understand
mechan
develop
fip
fcov
infect
urgent
practic
import
cat
owner
term
husbandri
measur
associ
multicat
environ
height
antibodi
titer
preval
fcov
infect
found
studi
confirm
report
associ
fcov
serotyp
clinic
manifest
antibodi
type
overrepres
diseas
cat
addit
tendenc
type
less
often
present
howev
statist
signific
level
similarli
japan
chronic
diseas
cat
test
posit
fcov
type
type
respect
thu
fcov
type
virus
may
like
replic
high
viral
load
induc
higher
antibodi
titer
therebi
may
becom
frequent
associ
chronic
diseas
andor
fip
explain
better
adapt
type
cat
studi
confirm
fip
case
seroposit
fcov
high
seropreval
fip
case
significantli
higher
healthi
cat
popul
correspond
well
found
studi
fip
sampl
test
posit
type
type
similarli
could
find
singl
fip
case
test
higher
type
thu
mention
hypothesi
fcov
type
higher
pathogen
type
appear
true
also
fip
develop
although
confirm
fip
case
show
significantli
increas
antibodi
titer
fcov
signific
associ
could
found
height
titer
categori
clinic
sign
immunolog
relationship
fcov
type
tegv
implic
serotest
statist
signific
correl
antibodi
titer
fcov
fcov
fcov
suggest
close
immunolog
relationship
fig
becom
evid
tgev
ifa
substrat
allow
detect
cat
seroposit
would
detect
use
fcov
fcov
antigen
low
titer
sampl
titer
titer
suggest
tgev
may
better
substrat
ie
produc
higher
concentr
viral
antigen
pig
cell
line
fcov
grown
cat
cell
altern
antibodi
present
sampl
could
induc
third
type
fcov
current
known
close
relat
tgev
fcov
diagnosi
clinic
fip
tgev
equal
suit
fcov
therefor
fip
diagnosi
either
fcov
tgev
use
emphas
howev
coronaviru
titer
alon
must
use
singl
paramet
fip
diagnosi
howev
seroposit
detect
tgev
pig
cell
appear
better
suit
conclus
demonstr
fcov
type
preval
fcov
serotyp
switzerland
distribut
quit
similar
part
world
inform
may
import
develop
futur
fcov
vaccin
differenti
antibodi
respons
fcov
seem
help
obtain
inform
diseas
process
given
cat
howev
antigen
use
studi
prove
highli
valuabl
differenti
antibodi
specif
fcov
